Exencial Wealth Advisors LLC Takes Position in HCA Healthcare, Inc. (NYSE:HCA)

Exencial Wealth Advisors LLC purchased a new stake in HCA Healthcare, Inc. (NYSE:HCAFree Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 856 shares of the company’s stock, valued at approximately $232,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in HCA. Stone House Investment Management LLC acquired a new position in HCA Healthcare in the 3rd quarter worth $25,000. Centerpoint Advisors LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth about $27,000. Atlantic Edge Private Wealth Management LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth about $27,000. Bruce G. Allen Investments LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth about $28,000. Finally, Annis Gardner Whiting Capital Advisors LLC acquired a new position in shares of HCA Healthcare during the 3rd quarter worth about $30,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. TD Cowen reduced their price objective on shares of HCA Healthcare from $371.00 to $360.00 and set a “buy” rating for the company in a research note on Tuesday, April 30th. Robert W. Baird began coverage on shares of HCA Healthcare in a report on Thursday, May 30th. They issued an “outperform” rating and a $396.00 target price on the stock. Royal Bank of Canada upped their target price on shares of HCA Healthcare from $322.00 to $329.00 and gave the company an “outperform” rating in a report on Monday, April 29th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $335.00 target price on shares of HCA Healthcare in a report on Wednesday, April 10th. Finally, StockNews.com raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday. Four investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $325.59.

Get Our Latest Stock Analysis on HCA

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Chad J. Wasserman sold 344 shares of the firm’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $321.97, for a total value of $110,757.68. Following the sale, the senior vice president now owns 2,452 shares in the company, valued at $789,470.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other HCA Healthcare news, SVP Chad J. Wasserman sold 344 shares of the firm’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $321.97, for a total value of $110,757.68. Following the sale, the senior vice president now owns 2,452 shares in the company, valued at $789,470.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Kathryn A. Torres sold 973 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total transaction of $303,576.00. Following the completion of the sale, the senior vice president now owns 22,365 shares in the company, valued at approximately $6,977,880. The disclosure for this sale can be found here. Insiders have sold 13,617 shares of company stock worth $4,321,986 over the last quarter. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Up 0.2 %

Shares of HCA opened at $337.44 on Friday. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $340.00. The firm’s 50 day moving average is $319.40 and its 200-day moving average is $310.70. The stock has a market capitalization of $88.38 billion, a PE ratio of 16.82, a P/E/G ratio of 1.57 and a beta of 1.69. The company has a current ratio of 1.16, a quick ratio of 1.02 and a debt-to-equity ratio of 29.26.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings results on Friday, April 26th. The company reported $5.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.01 by $0.35. The business had revenue of $17.34 billion for the quarter, compared to analyst estimates of $16.81 billion. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The firm’s revenue for the quarter was up 11.2% on a year-over-year basis. During the same quarter last year, the business posted $4.93 EPS. Equities research analysts forecast that HCA Healthcare, Inc. will post 20.92 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 14th will be given a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, June 14th. This represents a $2.64 annualized dividend and a dividend yield of 0.78%. HCA Healthcare’s dividend payout ratio is 13.16%.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Recommended Stories

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.